⚠️

Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.

Exposure to SARS-CoV-2

3,826 total reports30.5% serious outcomes

3,826

Total Reports

147

Deaths

1,020

Hospitalizations

30.5

Severity Rate

% serious outcomes

About Exposure to SARS-CoV-2 Reports

Exposure to SARS-CoV-2 has been reported 3,826 times in VAERS from 1990 to 2026.

Of these reports, 147 were associated with death (3.84%) and 1,020 involved hospitalization.

The overall serious outcome rate (death or hospitalization) for reports mentioning Exposure to SARS-CoV-2 is 30.5%.

Understanding Exposure to SARS-CoV-2 in VAERS

•Temporal association only: These reports show Exposure to SARS-CoV-2 occurred after vaccination, not necessarily because of vaccination.

•Background rates matter: Many symptoms occur naturally at baseline rates in the population, unrelated to vaccination.

•Reporting variability: Medical terminology may be used differently by various healthcare providers and over time.

•Investigation needed: High-frequency reports may trigger further epidemiological studies to determine causation.

What This Data Shows

Most Associated Vaccines: The vaccines most frequently mentioned in reports with Exposure to SARS-CoV-2. This may reflect usage patterns, not causation.

Severity Patterns: The percentage of reports that involve serious outcomes can help prioritize safety investigations.

Reporting Trends: Changes in reporting frequency over time may reflect increased awareness, media attention, or actual safety signals.